Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • anda

    Tag: anda

    You Searched For "anda"
    Swiss company Actelion moves US court against Natco Pharma over generic of its patented drug

    Swiss company Actelion moves US court against Natco Pharma over generic of its patented drug

    Medical Dialogues Bureau5 Jun 2019 12:27 PM IST
    Hyderabad: Swiss pharma company Actelion Pharmaceuticals Ltd has filed a petition in a US court alleging that Natco Pharma and its US partner Syneos...
    Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension

    Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension

    Farhat Nasim5 Jun 2019 10:00 AM IST
    Bosentan 32 mg tablets are sold by Actelion Pharmaceuticals US, Inc. (acquired by Johnson and Johnson) under the brand name Tracleer.Hyderabad:...
    Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis

    Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis

    Medical Dialogues Bureau1 Jun 2019 2:39 PM IST
    New Delhi: Natco Pharma Thursday said it has settled patent litigation with Onyx Therapeutics Inc in the US over a generic version of Kyprolis, an...
    Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis

    Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis

    Medical Dialogues Bureau30 May 2019 5:12 PM IST
    Kyprolis is the trade name for the generic drug Carfilzomib. The anti-cancer drug is a targeted therapy and is classified as a Proteasome Inhibitor....
    Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

    Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

    Farhat Nasim28 May 2019 10:00 AM IST
    The approved product, Methylphenidate Hydrochloride extended-release capsules, is bioequivalent to the reference listed drug product (RLD), Ritalin LA...
    Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine

    Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine

    Farhat Nasim22 May 2019 9:45 AM IST
    Azacitidine is a chemotherapy drug used to treat myelodysplastic syndromes (MDS) with annual sales of about USD 110 million in US markets as per IQVIA...
    Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets

    Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets

    Farhat Nasim8 May 2019 10:15 AM IST
    Nitroglycerin sublingual tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood...
    Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

    Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

    Farhat Nasim2 May 2019 4:04 PM IST
    Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.New...
    Zydus Cadila gets USFDA nod for Phentermine Hydrochloride orally disintegrating tablets

    Zydus Cadila gets USFDA nod for Phentermine Hydrochloride orally disintegrating tablets

    Medical Dialogues Bureau26 April 2019 8:59 AM IST
    Phentermine Hydrochloride orally disintegrating tablets is used together with diet and exercise to treat obesity (overweight) in people with risk...
    Indoco Remedies: USFDA retains OAI status for Goa plant

    Indoco Remedies: USFDA retains OAI status for Goa plant

    Farhat Nasim25 April 2019 9:50 AM IST
    Indoco Remedies' spokesperson said that the move is likely to withhold approval of pending abbreviated new drug applications (ANDAs) from Goa...
    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Farhat Nasim15 April 2019 10:05 AM IST
    Bimatoprost Ophthalmic Solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular...
    USFDA inspected Goa facility, no observations issued: Indoco Remedies

    USFDA inspected Goa facility, no observations issued: Indoco Remedies

    Farhat Nasim30 March 2019 11:52 AM IST
    The US Food and Drug Administration (USFDA) has cleared the Goa-based sterile manufacturing facility of Indoco Remedies for finished dosages.New...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok